Illinois Hospital Report Card

and Consumer Guide to Health Care

Blessing Hospital

Patient Safety - CDI & MRSA

Clostridioides difficile infections (CDI) and Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections

Facility-wide Healthcare Facility Onset Incidence Rates for CDI and MRSA are presented below. These rates are based on results of laboratory tests that were obtained on or after day four of an inpatient stay and do not consider presence or timing of clinical signs or symptoms. The Standardized Infection Ratio (SIR) is presented, which is a summary measure used to determine if rates of CDI and MRSA bloodstream infections are statistically different from the national average. Statewide summaries of CDI and MRSA data arranged by hospital are also included. Note: Starting with 2016 data, new methods for risk adjustment were used.

Statistical Significance

Statistically significantly better than state average or performing at the best possible rate

Not statistically significantly better or worse than state average

Statistically significantly worse than state average

Healthcare Facility Onset Incidence Rate	Result	SIR
Methicillin-resistant Staphylococcus aureus (MRSA) blood stream infections Q1 2023 - Q4 2023 Result 3 infections, 77634 patient days Rating SIR: 0.51	3 infections, 77634 patient days	0.51
Description Methicillin-resistant Staphylococcus aureus infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 7 infections, 78128 patient days Rating SIR: 1.22	7 infections, 78128 patient days	1.22
Q1 2021 - Q4 2021 Result 6 infections, 78183 patient days Rating SIR: 1.12	6 infections, 78183 patient days	1.12
Q1 2020 - Q4 2020 Result 3 infections, 66824 patient days Rating SIR: 0.86	3 infections, 66824 patient days	0.86
Q1 2019 - Q4 2019 Result 2 infections, 50154 patient days Rating SIR: 0.60	2 infections, 50154 patient days	0.60
Q1 2018 - Q4 2018 Result 3 infections, 50134 patient days Rating SIR: 1.07	3 infections, 50134 patient days	1.07
Q1 2017 - Q4 2017 Result 2 infections, 50326 patient days Rating SIR: 0.63	2 infections, 50326 patient days	0.63
Q1 2016 - Q4 2016 Result 4 infections, 52478 patient days Rating SIR: 1.16	4 infections, 52478 patient days	1.16
Q1 2015 - Q4 2015 Result 2 infections, 60942 patient days Rating SIR: 0.86	2 infections, 60942 patient days	0.86
Q1 2014 - Q4 2014 Result 3 infections, 73057 patient days Rating SIR: 0.97	3 infections, 73057 patient days	0.97
Q1 2013 - Q4 2013 Result 0 infections, 63113 patient days Rating SIR: 0.00	0 infections, 63113 patient days	0.00
Q1 2012 - Q4 2012 Result 6 infections, 62994 patient days Rating SIR: 2.33	6 infections, 62994 patient days	2.33
Q1 2012 - Q2 2012 Result 3 infections, 33012 patient days Rating SIR: 0.91	3 infections, 33012 patient days	0.91
Clostridioides difficile infections (CDI) Q1 2023 - Q4 2023 Result 25 infections, 75503 patient days Rating SIR: 0.47	25 infections, 75503 patient days	0.47
Description Clostridium difficile infections summarized as a Standardized Infection Ratio Historical Data
Measure	Result	Rating
Q1 2022 - Q4 2022 Result 21 infections, 76240 patient days Rating SIR: 0.45	21 infections, 76240 patient days	0.45
Q1 2021 - Q4 2021 Result 24 infections, 76274 patient days Rating SIR: 0.54	24 infections, 76274 patient days	0.54
Q1 2020 - Q4 2020 Result 21 infections, 64822 patient days Rating SIR: 0.53	21 infections, 64822 patient days	0.53
Q1 2019 - Q4 2019 Result 24 infections, 47930 patient days Rating SIR: 0.68	24 infections, 47930 patient days	0.68
Q1 2018 - Q4 2018 Result 52 infections, 47608 patient days Rating SIR: 1.28	52 infections, 47608 patient days	1.28
Q1 2017 - Q4 2017 Result 65 infections, 47774 patient days Rating SIR: 1.52	65 infections, 47774 patient days	1.52
Q1 2016 - Q4 2016 Result 59 infections, 49740 patient days Rating SIR: 1.55	59 infections, 49740 patient days	1.55
Q1 2015 - Q4 2015 Result 39 infections, 58424 patient days Rating SIR: 0.82	39 infections, 58424 patient days	0.82
Q1 2014 - Q4 2014 Result 45 infections, 70550 patient days Rating SIR: 0.79	45 infections, 70550 patient days	0.79
Q1 2013 - Q4 2013 Result 27 infections, 60439 patient days Rating SIR: 0.55	27 infections, 60439 patient days	0.55
Q1 2012 - Q4 2012 Result 45 infections, 60410 patient days Rating SIR: 0.94	45 infections, 60410 patient days	0.94